GPCRomics: An Approach to Discover GPCR Drug Targets
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
G protein-coupled receptors (GPCRs) are targets for ~35% of approved drugs but only ~15% of the ~800 human GPCRs are currently such targets. GPCRomics, the use of unbiased, hypothesis-generating methods (e.g., RNA-sequencing [RNA-seq]), with tissues and cell types to identify and quantify GPCR expression, has led to the discovery of previously unrecognized GPCRs that contribute to functional responses and pathophysiology and that may be therapeutic targets. The combination of GPCR expression data with validation studies (e.g., signaling and functional activities) provides opportunities for the discovery of disease-relevant GPCR targets and therapeutics. Here, we review insights from GPCRomic approaches, gaps in knowledge and future directions by which GPCRomics can advance GPCR biology and the discovery of new GPCR-targeted drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723 · cited 2×
“The FASTQ files are then input into Kallisto [36], an ‘alignment-free’, fast and computationally cheap method [33] that estimates transcript expression.”
MethodSzklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw937 · Cited by 6,980
Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences
Soneson, C., Love, M. I., & Robinson, M. D. (2015) · F1000Research · doi:10.12688/f1000research.7563.1 · Cited by 3,929
A survey of best practices for RNA-seq data analysis
Conesa, A., Madrigal, P., Tarazona, S., Gomez-Cabrero, D., Cervera, A., McPherson, A., Szcześniak, M. W., Gaffney, D. J., Elo, L. L., Zhang, X., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0881-8 · Cited by 2,794 · cited 4×
“A typical RNA-seq workflow (Figure 1) begins with the isolation of minimally degraded RNA [33] and its conversion (using standard methods, e.”
MethodInfluentialDifferential analysis of RNA-seq incorporating quantification uncertainty
Pimentel, H., Bray, N. L., Puente, S., Melsted, P., & Pachter, L. (2017) · Nature Methods · doi:10.1038/nmeth.4324 · Cited by 1,534
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Sriram, K., & Insel, P. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111062 · Cited by 1,258
Self-citationStructure and dynamics of GPCR signaling complexes
Hilger, D., Masureel, M., & Kobilka, B. K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0011-7 · Cited by 969
Selectivity determinants of GPCR–G-protein binding
Flock, T., Hauser, A. S., Lund, N., Gloriam, D. E., Balaji, S., & Babu, M. M. (2017) · Nature · doi:10.1038/nature22070 · Cited by 384
Research works printed but not linked: 71
- Milligan, 2018, G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35, Br. J. Pharmacol., 175, 2543, 10.1111/bph.14042 · DOI
- Insel, 2015, G protein-coupled receptor (GPCR) expression in native cells: “novel” endoGPCRs as physiologic regulators and therapeutic targets, Mol. Pharmacol., 88, 181, 10.1124/mol.115.098129 · DOI
- Ahlquist, 1948, A study of the adrenotropic receptors, Am. J. Physiol., 153, 586, 10.1152/ajplegacy.1948.153.3.586 · DOI · Paper page
- Wu, 2017, Structure and function of peptide-binding G protein-coupled receptors, J. Mol. Biol., 429, 2726, 10.1016/j.jmb.2017.06.022 · DOI
- Vass, 2018, Chemical diversity in the G protein-coupled receptor superfamily, Trends Pharmacol. Sci., 39, 494, 10.1016/j.tips.2018.02.004 · DOI
- Thal, 2018, Recent advances in the determination of G protein-coupled receptor structures, Curr. Opin. Struct. Biol., 51, 28, 10.1016/j.sbi.2018.03.002 · DOI
- Manglik, 2017, Structural basis for G protein-coupled receptor activation, Biochemistry, 56, 5628, 10.1021/acs.biochem.7b00747 · DOI · Paper page
- Thal, 2018, Structural insights into G-protein-coupled receptor allostery, Nature, 559, 45, 10.1038/s41586-018-0259-z · DOI · Paper page
- Munk, 2019, An online resource for GPCR structure determination and analysis, Nat. Methods, 16, 151, 10.1038/s41592-018-0302-x · DOI
- Wootten, 2018, Mechanisms of signalling and biased agonism in G protein-coupled receptors, Nat. Rev. Mol. Cell Biol., 19, 638, 10.1038/s41580-018-0049-3 · DOI · Paper page
- Smith, 2018, Biased signalling: from simple switches to allosteric microprocessors, Nat. Rev. Drug Discov., 17, 243, 10.1038/nrd.2017.229 · DOI · Paper page
- Milligan, 2019, GPCR homo-oligomerization, Curr. Opin. Cell Biol., 57, 40, 10.1016/j.ceb.2018.10.007 · DOI · Paper page
- Gurevich, 2018, GPCRs and signal transducers: interaction stoichiometry, Trends Pharmacol. Sci., 39, 672, 10.1016/j.tips.2018.04.002 · DOI
- Weinberg, 2018, Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis, Traffic, 20, 121, 10.1111/tra.12628 · DOI
- Maiga, 2016, Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets, Blood Cancer J., 6, 10.1038/bcj.2016.36 · DOI
- Koyama, 2016, Comprehensive profiling of GPCR expression in ghrelin-producing cells, Endocrinology, 157, 692, 10.1210/en.2015-1784 · DOI
- Amisten, S. (2016) Quantification of the mRNA expression of G protein-coupled receptors in human adipose tissue. In G Protein-Coupled Receptors (Vol. 132) (Shukla, K., ed.), pp. 73–105, Academic Press. · DOI
- Flegel, 2016, Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18, Sci. Rep., 6, 32255, 10.1038/srep32255 · DOI
- Liang, 2016, Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia, Placenta, 40, 52, 10.1016/j.placenta.2016.02.015 · DOI
- Balenga, 2017, Orphan adhesion GPCR GPR64/ADGRG2 is overexpressed in parathyroid tumors and attenuates calcium-sensing receptor-mediated signaling, J. Bone Miner. Res., 32, 654, 10.1002/jbmr.3023 · doi:10.1002/jbmr.3023
- Amisten, 2017, A comparative analysis of human and mouse islet G-protein coupled receptor expression, Sci. Rep., 7, 46600, 10.1038/srep46600 · DOI
- Bhat, 2018, GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer, Breast Cancer Res. Treat., 170, 279, 10.1007/s10549-018-4751-9 · DOI
- Roberts, 2018, The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response, Respir. Res., 19, 56, 10.1186/s12931-018-0759-2 · DOI
- Kübler, 2018, Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines, Oncotarget, 9, 24882, 10.18632/oncotarget.25427 · DOI
- Ehrlich, 2018, Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research, Commun. Biol., 1, 102, 10.1038/s42003-018-0106-7 · DOI · Paper page
- Flegel, 2015, RNA-seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors, PLoS One, 10, 10.1371/journal.pone.0128951 · DOI · Paper page
- Ray, 2018, Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq–based resource for pain and sensory neuroscience research, Pain, 159, 1325, 10.1097/j.pain.0000000000001217 · DOI · Paper page
- Insel, 2018, GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets, Front. Pharmacol., 9, 431, 10.3389/fphar.2018.00431 · DOI
- Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- Ogata, 1999, KEGG: Kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 27, 29, 10.1093/nar/27.1.29 · DOI · Paper page
- Piltonen, 2018, Alternative splicing of the delta-opioid receptor gene suggests existence of new functional isoforms, Mol. Neurobiol.
- Markovic, 2009, Alternative splicing of G protein-coupled receptors: physiology and pathophysiology, Cell. Mol. Life Sci., 66, 3337, 10.1007/s00018-009-0093-4 · DOI
- Harding, 2018, The IUPHAR/BPS guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology, Nucleic Acids Res., 46, D1091, 10.1093/nar/gkx1121 · DOI · Paper page
- Snead, 2012, Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts, FASEB J., 26, 4540, 10.1096/fj.12-213496 · DOI
- Walker, 2015, A second trigeminal CGRP receptor: function and expression of the AMY 1 receptor, Ann. Clin. Transl. Neurol., 2, 595, 10.1002/acn3.197 · DOI · Paper page
- Jung, 2016, Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation, FASEB J., 30, 1464, 10.1096/fj.15-280982 · DOI
- Klepac, 2016, The Gq signalling pathway inhibits brown and beige adipose tissue, Nat. Commun., 7, 10895, 10.1038/ncomms10895 · DOI
- Wiley, 2018, GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells, FASEB J., 32, 1170, 10.1096/fj.201700834R · DOI · Paper page
- Mukherjee, 2019, Prostaglandin E2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca2+ signaling, Am. J. Physiol. Lung Cell Mol. Physiol., 316, L810, 10.1152/ajplung.00403.2018 · DOI
- Spaethling, 2016, Single-cell transcriptomics and functional target validation of brown adipocytes show their complex roles in metabolic homeostasis, FASEB J., 30, 81, 10.1096/fj.15-273797 · DOI · Paper page
- Spaethling, 2014, Serotonergic neuron regulation informed by in vivo single-cell transcriptomics, FASEB J., 28, 771, 10.1096/fj.13-240267 · DOI · Paper page
- Tischner, 2017, Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation, JCI Insight, 2, 95063, 10.1172/jci.insight.95063 · DOI
- Kaur, 2017, Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system, Nat. Commun., 8, 15700, 10.1038/ncomms15700 · DOI · Paper page
- Koussounadis, 2015, Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system, Sci. Rep., 5, 10775, 10.1038/srep10775 · DOI · Paper page
- Edfors, 2016, Gene-specific correlation of RNA and protein levels in human cells and tissues, Mol. Syst. Biol., 12, 883, 10.15252/msb.20167144 · DOI · Paper page
- Beermann, 2012, Commercially available antibodies against human and murine histamine H4-receptor lack specificity, Naunyn. Schmiedebergs. Arch. Pharmacol., 385, 125, 10.1007/s00210-011-0700-4 · DOI
- Marchalant, 2014, Validating antibodies to the cannabinoid CB2 receptor, J. Histochem. Cytochem., 62, 395, 10.1369/0022155414530995 · DOI · Paper page
- Liu, 2018, In vivo brain GPCR signaling elucidated by phosphoproteomics, Science, 360, 10.1126/science.aao4927 · DOI · Paper page
- Xiao, 2018, Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics, Cell Signal., 41, 56, 10.1016/j.cellsig.2017.09.013 · DOI
- Mincarelli, 2018, Defining cell identity with single-cell omics, Proteomics, 18, 10.1002/pmic.201700312 · DOI
- Tréfier, 2018, Investigation methods to explore G protein-coupled receptor-regulated translatome, C. R. Biol., 341, 65, 10.1016/j.crvi.2017.12.002 · DOI
- Atwood, 2011, Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis, BMC Genomics, 12, 18, 10.1186/1471-2164-12-14 · DOI · Paper page
- Aust, 2016, Adhesion GPCRs in tumorigenesis, Handb. Exp. Pharmacol., 234, 369, 10.1007/978-3-319-41523-9_17 · DOI
- Nohata, 2017, Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer, J. Hum. Genet., 62, 87, 10.1038/jhg.2016.124 · DOI
- Moody, 2018, Neuropeptide G protein-coupled receptors as oncotargets, Front. Endocrinol. (Lausanne), 9, 345, 10.3389/fendo.2018.00345 · DOI
- Ma, 2018, Application of nanoparticles for targeting G protein-coupled receptors, Int. J. Mol. Sci., 19, E2006, 10.3390/ijms19072006 · doi:10.3390/ijms19072006
- Zeng, 2018, Frizzled receptors as potential therapeutic targets in human cancers, Int. J. Mol. Sci., 19, E1543, 10.3390/ijms19051543 · DOI
- Nieto Gutierrez, 2018, GPCRs: emerging anti-cancer drug targets, Cell Signal., 41, 65, 10.1016/j.cellsig.2017.09.005 · DOI · Paper page
- Nugent, 2017, The role of G protein-coupled receptors in lymphoid malignancies, Cell Signal., 39, 95, 10.1016/j.cellsig.2017.08.002 · doi:10.1016/j.cellsig.2017.08.002
- Masuho, 2015, Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors, Sci. Signal., 8, ra123, 10.1126/scisignal.aab4068 · DOI · Paper page
- Sokolina, 2017, Systematic protein-protein interaction mapping for clinically relevant human GPCRs, Mol. Syst. Biol., 13, 918, 10.15252/msb.20167430 · DOI · Paper page
- Atanes, 2018, Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets, Cell. Mol. Life Sci., 75, 3039, 10.1007/s00018-018-2778-z · DOI
- Crépieux, 2017, A comprehensive view of the β-arrestinome, Front. Endocrinol. (Lausanne), 8, 32, 10.3389/fendo.2017.00032 · DOI
- Nag, 2018, Transcriptional landscape of PARs in epithelial malignancies, Int. J. Mol. Sci., 19, 3451, 10.3390/ijms19113451 · DOI
- Itcho, 2018, Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma, Mol. Cell. Endocrinol., 461, 100, 10.1016/j.mce.2017.08.019 · DOI
- Law, 2017, Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology, Am. J. Physiol. Gastrointest. Liver Physiol., 313, G361, 10.1152/ajpgi.00144.2017 · DOI
- Cazorla-Vázquez, 2018, Adhesion GPCRs in kidney development and disease, Front. Cell Dev. Biol., 6, 9, 10.3389/fcell.2018.00009 · DOI
- Jiang, 2018, GPRC5A: an emerging biomarker in human cancer, Biomed. Res. Int., 2018, 1
- Matters, 2018, Utilizing peptide ligand GPCRs to image and treat pancreatic cancer, Biomedicines, 6, E65, 10.3390/biomedicines6020065 · DOI
- Medapati, M.R. et al. (2017) Characterization of GPCRs in extracellular vesicle (EV). In G Protein-Coupled Receptors Part A (Vol. 142) (Shukla, K.., ed.), pp. 119–132, Academic Press. · DOI
- El Buri, 2018, The sphingosine 1-phosphate receptor 2 is shed in exosomes from breast cancer cells and is N-terminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts, Oncotarget, 9, 29453, 10.18632/oncotarget.25658 · DOI
Cited by
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Schmidt, M., Cattani-Cavalieri, I., Nuñez, F. J., & Ostrom, R. S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.05.002 · Cited by 30
“Importantly, it has been reported recently that G a s -coupled receptors such as the b 2 -AR and receptors for prostaglandin E 2 (PGE 2 ) are repressed in IPF lungs [20–22].”
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
Raymond, J. H., Aktary, Z., Larue, L., & Delmas, V. (2022) · Cancers · doi:10.3390/cancers14030706 · Cited by 20
Metadata
- Authors
- Insel, P. A., Sriram, K., Gorr, M. W., Wiley, S. Z., Michkov, A., Salmerón, C., & Chinn, A. M.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 40
- Issue
- 6
- Pages
- 378-387
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2944441714
- Cited by
- 178
- References
- 16
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 363 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Institute of Health (HL098062, GM007752, CA121938, HL007444, CA189477, AG053568)
- Department of Defense (W81XWH-14-1-0372)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GPCRomics: An Approach to Discover GPCR Drug Targets. https://app.cochat.ai/papers/10.1016/j.tips.2019.04.001
- The paper
- Insel, P. A., Sriram, K., Gorr, M. W., Wiley, S. Z., Michkov, A., Salmerón, C., & Chinn, A. M. (2019). GPCRomics: An Approach to Discover GPCR Drug Targets. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2019.04.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.